It also underscores the need for additional research to elucidate the function of specific molecules, such as S100A16 [204], in facilitating the spread of cancer to the brain and to discover new therapeutic targets that could transform treatment for SCLC patients. Here, S100A16 is linked to small cell lung carcinoma.